Andere talen Albert Labs International Corp.

Aandelen

ABRT

CA0127841041

slotkoers Canadian Securities Exchange Andere beurzen 00:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,015 ^CAD	+50,00%		-25,00%	+50,00%

2023	Albert Labs International Corp. Rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI
2023	Albert Labs International Corp. Benoemt Shabir Hasham tot lid van de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Albert Labs International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
Albert Labs International Corp. Appoints Shabir Hasham to Its Board of Directors	18-10-23
Albert Labs International Corp. Announces Resignation of Michael Raymont as Board of Directors	05-09-23
Albert Labs International Corp. Announces CEO Changes	05-09-23
Albert Labs International Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28-08-23
CSE Bulletin: Reinstatement - Albert Labs International Corp. (ABRT)	07-07-23
Canadian Investment Regulatory Organization Trade Resumption - ABRT	07-07-23
Albert Labs International Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	07-06-23
Albert Labs International Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	02-06-23
Albert Labs International Corp. Auditor Raises 'Going Concern' Doubt	02-06-23
CSE Bulletin: Suspensions - ADMT, ABRT, CFT, GAIA, IWIN, PKG, POLE, PRTI, RWB, CALM, RVR, VEJI	09-05-23
IIROC Trading Halt - ABRT	09-05-23
Albert Labs International Corp. Announces Preliminary Acceptance of 35 Novel Innovative Claims	02-05-23
Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology	02-05-23
Albert Labs announces Private Placement	24-04-23
Albert Labs International Corp. announced that it expects to receive CAD 3 million in funding	24-04-23
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human Trials	28-03-23
Albert Labs International Corp. announced that it expects to receive CAD 0.83 million in funding from Cantheon Capital	23-03-23
Albert Labs Validates Global Supply Chain for Controlled Substances	15-03-23
Albert Labs International Corp. announced that it has received CAD 0.3 million in funding	24-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Albert Labs International Corp.

Aandelen

ABRT

CA0127841041

Andere talen

Filters